A completely integrated microfluidic genetic analysis system with sample-in-answer-out capability In an accomplishment that represents a substantial step toward an era of rapid, inexpensive, bedside testing for cancer, researchers at the University of Virginia have developed a microfluidic device thatContinue reading… Bedside testing for cancer.
Day: July 10, 2017
As well as its wholly-owned subsidiary.
With this dedicated facility, clients can reap the benefits of an extended selection of mass spectrometry solutions now, like the quantitation of genotoxic impurities, bioanalysis, structure elucidation, isotopic purity determinations and high resolution mass spectrometry of both small and largeContinue reading… As well as its wholly-owned subsidiary.